TIZANIDINE HYDROCHLORIDE
- Product NDC
- 61919-196
- Requested package NDC
- 61919-196-40
- 11-digit product format
- 619190196
- Labeler code
- 61919
- Product ID
- 61919-196_4c484458-33e2-e0cc-e063-6294a90a9e28
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TIZANIDINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- TIZANIDINE HYDROCHLORIDE
- Application
- ANDA091283
- Marketing category
- ANDA
- Marketing start
- 2014-01-01
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091283-001 | TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2012-11-28 | |
| A091283-002 | TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2012-11-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091283-001 | AB |
| A091283-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091283-001 | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2012-11-28 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091283-002 | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2012-11-28 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091283-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091283-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tizanidine | TIZANIDINE | NuCare Pharmaceuticals,Inc. | 6dd9946f-b2a4-1732-e053-2a91aa0a648f | 2026-07-24 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | REMEDYREPACK INC. | b14bd166-9f53-4f2e-be05-c447af04ef69 | 2026-07-08 | Warnings, Adverse reactions | 091283 ANDA091283 |
| TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | 047c67cd-7a63-49c9-b100-71651d3537ba | 2026-03-05 | Warnings, Adverse reactions | 091283 ANDA091283 61919-196-40 61919-196 61919019640 |
| TIZANDINE | TIZANDINE | Direct_Rx | 9003cb5d-f9d6-7183-e053-2995a90ad6e8 | 2026-03-05 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | A-S Medication Solutions | 308d2fdc-6136-4e75-95d3-342497add66c | 2026-02-13 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | A-S Medication Solutions | 9fd932fb-033c-4774-ac09-c823db8f9739 | 2026-02-12 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | Redpharm Drug | 49adcfc8-3b1d-7f7e-e063-6294a90a361e | 2026-01-31 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | 615dfd5c-125a-40e2-a6da-afacde305282 | 2025-07-17 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | Unichem Pharmaceuticals (USA), Inc. | a3fa9c69-4baf-44f5-bac4-a19c34b0e1cb | 2025-05-27 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | A-S Medication Solutions | 9678a98e-4aab-4d87-b5e1-37c3109e378e | 2025-04-02 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | Bryant Ranch Prepack | f87e30ce-a60a-41e3-b5d6-7e2966143961 | 2025-02-19 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | Preferred Pharmaceuticals Inc. | 6e97c1ba-8171-4707-98ee-61afed75daac | 2025-01-02 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine HCL | TIZANIDINE HCL | Advanced Rx of Tennessee, LLC | afc96ee6-c99b-7283-e053-2a95a90ad14d | 2024-12-31 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | Advanced Rx Pharmacy of Tennessee, LLC | d2961d1c-5de2-0a2b-e053-2995a90ad2fc | 2024-09-12 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | Proficient Rx LP | e13b111a-25b7-4fdd-a102-30f2996722f3 | 2024-02-01 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | Proficient Rx LP | 5b7b4721-e6fa-4586-ac40-091ad363ee85 | 2022-04-01 | Warnings, Adverse reactions | 091283 ANDA091283 |
| Tizanidine | TIZANIDINE | Aphena Pharma Solutions - Tennessee, LLC | ea242c7d-b101-4197-8e65-b2b079e3b2b6 | 2019-02-11 | Warnings, Adverse reactions | 091283 ANDA091283 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TIZANIDINE HYDROCHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TIZANIDINE HYDROCHLORIDE | 4 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| B53E3NMY5C | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 313413 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 047c67cd-7a63-49c9-b100-71651d3537ba | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a0ff02d8-b711-423c-b7d1-ada00d81c743 | Product name | 1 | 20250805 |
| 9fd28b3a-d1bb-a2ce-ffa3-c3dd28536a01 | Product name | 8 | 20250313 |
| b404127e-1c01-47bb-874e-db1e0b6bd9af | Product name | 4 | 20250313 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61919-196-30 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8331-d83d-e063-dadaa90ab31f | TIZANIDINE HYDROCHLORIDE |
| 61919-196-40 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8331-d83d-e063-dadaa90ab31f | TIZANIDINE HYDROCHLORIDE |
| 61919-196-60 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8331-d83d-e063-dadaa90ab31f | TIZANIDINE HYDROCHLORIDE |
| 61919-196-72 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8331-d83d-e063-dadaa90ab31f | TIZANIDINE HYDROCHLORIDE |
| 61919-196-90 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8331-d83d-e063-dadaa90ab31f | TIZANIDINE HYDROCHLORIDE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61919-196-20 | TIZANIDINE HYDROCHLORIDE | 20 in 1 BOTTLE | TABLET | 20 | 7 | |
| 61919-196-30 | TIZANIDINE HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 61919-196-40 | TIZANIDINE HYDROCHLORIDE | 40 in 1 BOTTLE | TABLET | 40 | 7 | |
| 61919-196-60 | TIZANIDINE HYDROCHLORIDE | 60 in 1 BOTTLE | TABLET | 60 | 7 | |
| 61919-196-72 | TIZANIDINE HYDROCHLORIDE | 72 in 1 BOTTLE | TABLET | 72 | 7 | |
| 61919-196-90 | TIZANIDINE HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET | 90 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61919-196-30 | EA - Each | 61919-196 | d9738507-dea3-4be7-b22f-54f870b42815 | 1 | 2015-04-03 |
| 61919-196-40 | EA - Each | 61919-196 | 531d7162-f55a-4f54-97fb-dc6d3a53d617 | 1 | 2021-07-15 |
| 61919-196-60 | EA - Each | 61919-196 | 3c5664c8-e3b7-49a1-b452-6250761e780c | 1 | 2015-04-03 |
| 61919-196-72 | EA - Each | 61919-196 | 398afc75-eec5-4737-90e2-35b0d20222cb | 1 | 2015-04-03 |
| 61919-196-90 | EA - Each | 61919-196 | 3e8bbb6b-c8c9-4c8b-81ef-dd2fc12dc442 | 1 | 2015-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TIZANIDINE HYDROCHLORIDE | ACTIVE INGREDIENT | B53E3NMY5C | TIZANIDINE HYDROCHLORIDE TABLET [TIZANIDINE HYDROCHLORIDE] | 1 | |
| TIZANIDINE | ACTIVE MOIETY | 6AI06C00GW | TIZANIDINE HYDROCHLORIDE TABLET [TIZANIDINE HYDROCHLORIDE] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | TIZANIDINE HYDROCHLORIDE TABLET [TIZANIDINE HYDROCHLORIDE] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | TIZANIDINE HYDROCHLORIDE TABLET [TIZANIDINE HYDROCHLORIDE] | 1 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | TIZANIDINE HYDROCHLORIDE TABLET [TIZANIDINE HYDROCHLORIDE] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | TIZANIDINE HYDROCHLORIDE TABLET [TIZANIDINE HYDROCHLORIDE] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 313413 | tiZANidine HCl 4 MG Oral Tablet | PSN | 047c67cd-7a63-49c9-b100-71651d3537ba | 7 |
| 313413 | tizanidine 4 MG Oral Tablet | SCD | 047c67cd-7a63-49c9-b100-71651d3537ba | 7 |
| 313413 | tizanidine 4 MG (as tizanidine HCl 4.576 MG) Oral Tablet | SY | 047c67cd-7a63-49c9-b100-71651d3537ba | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 61919-196-40 | 61919019640 | 40 TABLET in 1 BOTTLE (61919-196-40) | 40 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |